GleamWall
中文EN

SCLX Scilex Holding Co

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1820190 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-28.5%
TTM net income YoY-473.7%
TTM EPS YoY-2,120.1%
Revenue 3-yr CAGR-12.0%
Net income 3-yr CAGR—

Margins

Gross margin161.1%
Operating margin-1,136.4%
Net margin-1,469.8%
FCF margin—
EBITDA margin-1,119.8%

Returns

ROE—
ROA-275.4%
ROIC (approx.)—
Asset turnover0.19x

Leverage & solvency

Liabilities / assets222.5%
Debt / equity—
Current ratio0.07x
Interest coverage-22.20x

Cash quality & payout

Operating cash flow / net income0.04x
Accruals ratio-265.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$30.25M$56.59M
Cost of revenue$10.60M$16.69M
Gross profit$125.80M$167.40M
R&D expense$20.71M$9.64M
SG&A expense$266.88M$119.02M
Operating income-$346.01M-$83.40M
Interest expense$11.46M$1.96M
Pretax income-$374.03M-$72.81M
Income tax$26,000-$1,000
Net income-$374.05M-$72.81M
EBITDA-$341.38M-$79.35M
EPS (basic)-36.48-7.24
EPS (diluted)-36.48-8.05
Weighted avg. shares (diluted)11,03410,145
Balance sheet
Cash & equivalents$4.96M$3.27M
Receivables$15.24M$26.44M
Inventory$4.79M$2.44M
Current assets$38.36M$41.55M
PP&E, net$13.60M$708,000
Goodwill$13.48M$13.48M
Intangibles$59.09M$32.45M
Total assets$364.98M$92.95M
Current liabilities$483.65M$259.63M
Short-term debt$83.26M$34.88M
Total liabilities$576.73M$285.59M
Shareholders' equity-$207.78M-$192.64M
Shares outstanding7.03M5.24M
Cash flow statement
Operating cash flow$3.82M$19.35M
Capital expenditure$133,000$0
Free cash flow$3.68M$19.35M
Investing cash flow$4.08M-$2.67M
Financing cash flow-$5.46M-$18.13M
Depreciation & amortization$4.62M$4.05M
Stock-based compensation$15.49M$15.69M
Dividends paid—$8.65M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.